Search Results - "de Morais, Hely"

Akt activation by insulin treatment attenuates cachexia in Walker‐256 tumor‐bearing rats by Fatima Silva, Flaviane, Morais, Hely, Ortiz Silva, Milene, Silva, Francemilson Goulart, Vianna Croffi, Rafael, Serrano‐Nascimento, Caroline, Rodrigues Graciano, Maria Fernanda, Rafael Carpinelli, Angelo, Barbosa Bazotte, Roberto, Souza, Helenir Medri

“…Cancer‐bearing often exhibits hypoinsulinemia, insulin (INS) resistance and glutamine depletion associated with cachexia. However, INS and glutamine effects on…”
Get full text

Decreased hepatic response to glucagon, adrenergic agonists, and cAMP in glycogenolysis, gluconeogenesis, and glycolysis in tumor‐bearing rats by Biazi, Giuliana R., Frasson, Isabele G., Miksza, Daniele R., de Morais, Hely, de Fatima Silva, Flaviane, Bertolini, Gisele L., de Souza, Helenir M.

“…The response to glucagon and adrenaline in cancer cachexia is poorly known. The aim of this study was to investigate the response to glucagon, adrenergic…”
Get full text

Peripheral insulin resistance is early, progressive, and correlated with cachexia in Walker‐256 tumor‐bearing rats by Morais, Hely, Bôas, Suéllen Kathiane Fernandes Vilas, Souza, Camila O., Miksza, Daniele Romani, Moreira, Carolina C. L., Kurauti, Mirian Ayumi, Silva, Flaviane de F., Cassolla, Priscila, Silva, Francemilson Goulart da, Limiere, Leticia Cristina, Grassiolli, Sabrina, Bazotte, Roberto B., Souza, Helenir M.

“…Insulin (INS) resistance is often found in cancer‐bearing, but its correlation with cachexia development is not completely established. This study investigated…”
Get full text

Celecoxib and Ibuprofen Restore the ATP Content and the Gluconeogenesis Activity in the Liver of Walker-256 Tumor-Bearing Rats by de Souza, Camila Oliveira, Kurauti, Mirian Ayumi, de Fatima Silva, Flaviane, de Morais, Hely, Curi, Rui, Hirabara, Sandro Massao, Rosa Neto, José Cesar, de Souza, Helenir Medri

“…Background/Aims: The main purpose of this study was to investigate the effects of celecoxib and ibuprofen, both non-steroidal anti-inflammatory drugs (NSAIDs),…”
Get full text

Chronic Glibenclamide Treatment Attenuates Walker-256 Tumour Growth in Prediabetic Obese Rats by da Silva Franco, Claudinéia Conationi, Previate, Carina, de Barros Machado, Kátia Gama, Piovan, Silvano, Miranda, Rosiane Aparecida, Prates, Kelly Valério, Moreira, Veridiana Mota, de Oliveira, Júlio Cezar, Barella, Luiz Felipe, Gomes, Rodrigo Mello, Francisco, Flávio Andrade, Martins, Isabela Peixoto, Pavanello, Audrei, Ribeiro, Tatiane Aparecida, Tófolo, Laize Peron, Malta, Ananda, de Souza, Aline Amenencia, Alves, Vander Silva, da Silva Silveira, Sandra, Marçal Natali, Maria Raquel, Fernando Besson, Jean Carlos, de Morais, Hely, de Souza, Helenir Medri, de Sant Anna, Juliane Rocha, Alves de Castro Prado, Marialba Avezum, de Freitas Mathias, Paulo Cezar

“…Background/Aims: The sulphonylurea glibenclamide (Gli) is widely used in the treatment of type 2 diabetes. In addition to its antidiabetic effects, low…”
Get full text

Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats by de Souza, Camila Oliveira, Kurauti, Mirian Ayumi, de Fatima Silva, Flaviane, de Morais, Hely, Borba-Murad, Glaucia Regina, de Andrade, Fábio Goulart, de Souza, Helenir Medri

“…The contribution of anti-inflammatory property of celecoxib in the improvement of metabolic disorders in cancer is unknown. The purpose of this study was to…”
Get full text

Insulin, not glutamine dipeptide, reduces lipases expression and prevents fat wasting and weight loss in Walker 256 tumor-bearing rats by de Morais, Hely, de Fatima Silva, Flaviane, da Silva, Francemilson Goulart, Silva, Milene Ortiz, Graciano, Maria Fernanda Rodrigues, Martins, Maria Isabel Lovo, Carpinelli, Ângelo Rafael, Mazucco, Tânia Longo, Bazotte, Roberto Barbosa, de Souza, Helenir Medri

“…Cachexia is the main cause of mortality in advanced cancer patients. We investigated the effects of insulin (INS) and glutamine dipeptide (GDP), isolated or…”
Get full text

Decreased response to cAMP in the glucose and glycogen catabolism in perfused livers of Walker-256 tumor-bearing rats by de Morais, Hely, Cassola, Priscila, Moreira, Carolina Campos Lima, Bôas, Suéllen Kathiane Fernandes Vilas, Borba-Murad, Glaucia Regina, Bazotte, Roberto Barbosa, de Souza, Helenir Medri

“…The hepatic response to cyclic adenosine monophosphate (cAMP) and N6-monobutyryl-cAMP (N6-MB-cAMP) in the glucose and glycogen catabolism and hepatic glycogen…”
Get full text

Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats by Miksza, Daniele R., de Souza, Camila O., de Morais, Hely, da Rocha, Aline F., Borba-Murad, Gláucia R., Bazotte, Roberto B., de Souza, Helenir M.

“…The purpose of this study was to investigate the effect of infliximab, an anti-tumor necrosis factor a (TNFα) mono-clonal antibody, on the progression of…”
Get full text

Early treatment with metformin induces resistance against tumor growth in adult rats by Trombini, Amanda B, Franco, Claudinéia CS, Miranda, Rosiane A, de Oliveira, Júlio C, Barella, Luiz F, Prates, Kelly V, de Souza, Aline A, Pavanello, Audrei, Malta, Ananda, Almeida, Douglas L, Tófolo, Laize P, Rigo, Kesia P, Ribeiro, Tatiane AS, Fabricio, Gabriel S, de Sant'Anna, Juliane R, Castro-Prado, Marialba AA, de Souza, Helenir Medri, de Morais, Hely, Mathias, Paulo CF

“…It is known that antidiabetic drug metformin, which is used worldwide, has anti-cancer effects and can be used to prevent cancer growth. We tested the…”
Get full text

Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats by Moreira, Carolina Campos Lima, Cassolla, Priscila, Dornellas, Ana Paula Segantini, de Morais, Hely, de Souza, Camila Oliveira, Borba-Murad, Glaucia Regina, Bazotte, Roberto Barbosa, de Souza, Helenir Medri

“…Summary Few studies have investigated liver gluconeogenesis in cancer and there is no agreement as to whether the activity of this pathway is increased or…”
Get full text